Grasset E, Puel A, Charpentier J, Collet X, Christensen JE, Terce F, et al
In the primary Phase 2 clinical trial published in the New England Journal of Medicine (Jastreboff et al., 2023), retatrutide was studied across several dose levels, including: 1 mg (low dose) 4 mg (mid dose) 8 mg (higher dose) 12 mg (highest dose) These doses were administered as once-weekly subcutaneous injections
Supplements are a more reliable way to keep vitamin D levels up, which is important in winter or if you dont get much sun
Weeks 1 through 4: establishment phase Most theoretical frameworks suggest starting tesamorelin first, alone, for 2 to 4 weeks
In such cases, a positive Mendelian randomization result would indicate that any observed relationship between the traits is entirely due to the effects of exposure on the outcomes